Menu
The platform BC Link®, from Better Care, a biotechnology company that develops software solutions based on artificial intelligence for continuous patient monitoring, will be the first technology to be evaluated with the parameters agreed by all project participants ASSESS-DHT, whose objective is to standardize and harmonize the evaluation of Digital Health Technologies (DHT) for all of Europe.
Once the evaluation criteria for DHT are established at national and European levels, the working group responsible for case studies within the consortium, made up of 14 partners from 7 countries, will evaluate BC Link®, a DHT responsible for connecting, integrating and analyzing the biomedical data generated by any device along the entire healthcare route. The solution will be evaluated according to the established reference framework to check if the criteria are realistic and the implementation of DHT in European healthcare systems can be implemented into practice.
Xavier Garcia Ordoñez, CEO of Better Care, states that “we are grateful to the working group for involving us in a project in which we can contribute to a greater harmonization of evaluation criteria for digital health technologies in Europe. At Better Care, we work conscientiously and with great enthusiasm on our solutions and that is why we feel confident to be the first to evaluate our solutions according to the framework decided by the large working group that is part of ASSESS-DHT”. In this sense, Better Care plays a key role in the evaluation of DHT, being a reference in the validation of established standards.
European and multidisciplinary working group
For the launch of the ASSESS-DHT project, the entities that are part of the consortium responsible for developing it met in the city of Bonn (Germany), where they established the basis for starting work on the development of a framework for evaluating DHT. The purpose is to achieve a market that behaves as closely as possible to a single market, and that provides European patients, citizens and medical professionals with access to innovative products and solutions, as well as to facilitate their implementation in European healthcare systems.
Digital Health Technologies are a diverse group of technologies with great potential to improve patients' quality of life and enable new forms of healthcare delivery, even in some cases providing new access routes to populations that lack health centers in their vicinity.
The consortium, made up of 14 entities including national and regional technology assessment agencies, patient associations, university departments and private companies, is coordinated by i-HD, the European Institute for Innovation through Health Data, a European non-profit organization that facilitates the optimal uses of health data. The Progreso y Salud Foundation (FPS), an entity under the Ministry of Health and Consumer Affairs of the Junta de Andalucía, is responsible for leading the development of the methodological framework and laying the foundations for the evaluation of digital technologies.
How do you explain Miguel Ángel Armengol, director of the Big Data Area of the FPS, this work will allow the creation of “the adoption of a new approach for the validation and evaluation of applied artificial intelligence models. Connecting knowledge 2 will improve quality, efficiency and equity in healthcare, thus ensuring the reliability, safety and ethics of AI in health and facilitating evidence-based decision-making.”
The project will last a total of 3 years and has an investment from the European Commission of 6.5 million euros.
